Filters
Targeted biological therapy of stomach and esophagogastric junction cancers
Targeted biological therapy of stomach and esophagogastric junction cancers was summarized.
FD - Onkologie a hematologie
- 2012 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Targeted treatment of bronchogenic carcinoma
Targeted cancer therapies are drugs or other substances that block the growth and spread of cancer by interfering with specific molecules ("molecular targets") that are involved in the growth, progression...
Respiratory systems
- 2020 •
- JSC •
- Link
Rok uplatnění
JSC - Článek v periodiku v databázi SCOPUS
Výsledek na webu
Current possibilities to predict response to targeted therapy of colorectal cancer
Current possibilities to predict response to targeted therapy of colorectal cancer.
FP - Ostatní lékařské obory
- 2009 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Mitochondria, Apoptosis and Cancer: Targeting Mitochondria to Defeat Cancer
Biology and genetics of mitochondria in relation to cancer Role of mitochondria-targeting compounds in cancer suppression (including BH3 mimetics) Mitochondria as transmitters of death receptor-induced apoptosis Regulation ...
EB - Genetika a molekulární biologie
- 2009 •
- W
Rok uplatnění
W - Uspořádání workshopu
Emerging Anti-cancer Targets in Mitochondria
Extensive review of potential targets for anti-cancer treatment focusing on mitochondrial metabolism. Those targets include the mitochondrial isocitrate dehydrogenase-2 (IDH2), hexokinase-2 (HK2), and cancer?specif...
FD - Onkologie a hematologie
- 2014 •
- C •
- Link
Rok uplatnění
C - Kapitola v odborné knize
Výsledek na webu
Gefitinib - experience on biological targeted therapy of non-small-cell-lung cancer
Gefitinib - experience on biological targeted therapy of non-small-cell-lung cancer.
FC - Pneumologie
- 2004 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Targeted biological treatment of solid tumors. Controversy treatment HER2 dependent breast cancer
The current era of targeted cancer therapy was started after the discovery of hormone receptors, and targeted clinical use of tamoxifen....
FD - Onkologie a hematologie
- 2009 •
- D
Rok uplatnění
D - Stať ve sborníku
FoxM1 is a downstream target and marker of HER2 overexpression in breast cancer
The tyrosine kinase receptor, HER2 is a crucial prognostic marker and therapeutic target for breast cancer; however, the downstream targets and biological effectors of HER2 remain unclear. We investigated the relationship b...
FD - Onkologie a hematologie
- 2009 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Biological therapy for breast cancer
with chemotherapy inmetastatic breast cancer started the era of bioregulatory nonhormonal therapy for breast cancer (12). Targeted molecular therapy is no longer a mere subjectThe contemporary era of targeted, so-...
FD - Onkologie a hematologie
- 2009 •
- Jx
Rok uplatnění
Jx - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)
Mitocans Revisited: Mitochondrial Targeting as Efficient Anti-Cancer Therapy
of selective targeting of mitochondria and their functions to combat cancer, including and tamoxifen (MitoTam), selectively target cancer cell mitochondria and efficiently kill that mitochondrial metabolism and fu...
Biochemistry and molecular biology
- 2020 •
- Jimp •
- Link
Rok uplatnění
Jimp - Článek v periodiku v databázi Web of Science
Výsledek na webu
- 1 - 10 out of 49 168